Clustering of genomic inv(16)(p13q22) breakpoints in acute nonlymphocytic leukemia

被引：0

作者：

vanderReijden, BA ^{[1
]}

Wijmenga, C ^{[1
]}

Liu, P ^{[1
]}

Dauwerse, JG ^{[1
]}

Giles, RH ^{[1
]}

Changur, S ^{[1
]}

vanOmmen, GJ ^{[1
]}

Hagemeijer, A ^{[1
]}

Breuning, M ^{[1
]}

机构：

[1] LEIDEN UNIV,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS

来源：

BLOOD | 1995年 / 86卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2968 / 2968

页数：1

共 50 条

[21] Acquisition of Inv(16)(p13q22) in a blast crisis of chronic myeloid leukemia: case report [J].

Onate, Guadalupe ;

Laura Blanco, Maria ;

Pratcorona, Marta .

MEDICINA CLINICA, 2019, 152 (10) :419-420

[22] Nuclear factor kappa B is overexpressed in acute myeloid leukemia with inv(16)(p13q22) compared with acute myelomonocytic leukemia (M4) without inv16 [J].

Konoplev, S. ;

Sun, X. ;

Kantarjian, H. M. ;

Estey, E. H. ;

Medeiros, L. J. ;

Bueso-Ramos, C. E. .

LABORATORY INVESTIGATION, 2007, 87 :248A-249A

[23] Nuclear factor kappa B is overexpressed in acute myeloid leukemia with inv(16)(p13q22) compared with acute myelomonocytic leukemia (M4) without inv16 [J].

Konoplev, S. ;

Sun, X. ;

Kantarjian, H. M. ;

Estey, E. H. ;

Medeiros, L. J. ;

Bueso-Ramos, C. E. .

MODERN PATHOLOGY, 2007, 20 :248A-249A

[24] The prognostic significance of 3′ CBFB deletions in inv(16)(p13q22)/t(16;16)(p13;q22) [J].

Huxley, E ;

Griffiths, MJ ;

Talley, P ;

Whitworth, A ;

Humphreys, M ;

McKinley, M .

JOURNAL OF MEDICAL GENETICS, 2005, 42 :S81-S81

[25] RT-PCR DIAGNOSIS OF PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA AND INV(16)(P13Q22) AND IDENTIFICATION OF NEW ALTERNATIVE SPLICING IN CBFB-MYH11 TRANSCRIPTS [J].

VANDERREIJDEN, BA ;

LOMBARDO, M ;

DAUWERSE, HG ;

GILES, RH ;

MUHLEMATTER, D ;

BELLOMO, MJ ;

WESSELS, HW ;

BEVERSTOCK, GC ;

VANOMMEN, GJB ;

HAGEMEIJER, A ;

BREUNING, MH .

BLOOD, 1995, 86 (01) :277-282

[26] Unique signaling pathways in acute myeloid leukemia with inv(16)(p13q22) revealed by gene expression profiling. [J].

Sun, XP ;

Medeiros, LJ ;

Zhang, W ;

Ramdas, L ;

Glassman, AB ;

Taylor, E ;

Jones, D ;

Estey, EH ;

Buesco-Ramos, CE .

BLOOD, 2003, 102 (11) :377A-377A

[27] DO LEUKEMIA PATIENTS WITH CHROMOSOME-16 INVERSION INV(16)(P13Q22) HAVE A RARE FRAGILE SITE AT 16Q22 [J].

OHYASHIKI, K ;

OHYASHIKI, JH ;

TOYAMA, K ;

ITO, H .

CANCER GENETICS AND CYTOGENETICS, 1988, 31 (01) :31-34

[28] Inv(16)(p13q22) in chronic myelogenous leukemia: Clinical, morphologic and cytogenetic study of five cases [J].

Merzianu, M ;

Lin, P ;

Glassman, A ;

Hayes, K ;

Huh, Y .

MODERN PATHOLOGY, 2005, 18 :241A-242A

[29] Detection of inv(16)(p13q22) by means of chromosome painting with a 16q-specific probe [J].

Li, M ;

Xue, YQ ;

Wu, YF ;

Pan, JL .

CANCER GENETICS AND CYTOGENETICS, 2004, 150 (01) :86-87

[30] ACUTE MYELOMONOCYTIC LEUKEMIA WITH MARROW EOSINOPHILIA (M4EO) AND INV(16)(P13Q22) IN A PATIENT WITH A HERITABLE FRAGILE SITE 16Q22 [J].

ARTHUR, DC ;

AASENG, SM ;

BLOOMFIELD, CD .

CYTOGENETICS AND CELL GENETICS, 1985, 40 (1-4) :572-572

← 1 2 3 4 5 →